Compare Lupin with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs IPCA LABS - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN IPCA LABS LUPIN/
IPCA LABS
 
P/E (TTM) x 46.9 23.2 202.1% View Chart
P/BV x 4.3 8.3 51.9% View Chart
Dividend Yield % 0.5 0.1 344.0%  

Financials

 LUPIN   IPCA LABS
EQUITY SHARE DATA
    LUPIN
Mar-20
IPCA LABS
Mar-19
LUPIN/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs8821,042 84.7%   
Low Rs505590 85.6%   
Sales per share (Unadj.) Rs339.4298.6 113.7%  
Earnings per share (Unadj.) Rs-5.935.0 -17.0%  
Cash flow per share (Unadj.) Rs15.549.4 31.3%  
Dividends per share (Unadj.) Rs6.003.00 200.0%  
Dividend yield (eoy) %0.90.4 235.3%  
Book value per share (Unadj.) Rs276.7247.1 112.0%  
Shares outstanding (eoy) m453.00126.35 358.5%   
Bonus/Rights/Conversions ESOPESOS-  
Price / Sales ratio x2.02.7 74.8%   
Avg P/E ratio x-116.623.3 -500.2%  
P/CF ratio (eoy) x44.816.5 271.6%  
Price / Book Value ratio x2.53.3 75.9%  
Dividend payout %-100.98.6 -1,177.1%   
Avg Mkt Cap Rs m314,201103,108 304.7%   
No. of employees `00018.313.4 136.2%   
Total wages/salary Rs m29,8687,874 379.3%   
Avg. sales/employee Rs Th8,400.62,807.0 299.3%   
Avg. wages/employee Rs Th1,632.0585.8 278.6%   
Avg. net profit/employee Rs Th-147.2329.0 -44.7%   
INCOME DATA
Net Sales Rs m153,74837,732 407.5%  
Other income Rs m4,838577 838.7%   
Total revenues Rs m158,58538,309 414.0%   
Gross profit Rs m24,8496,901 360.1%  
Depreciation Rs m9,7021,824 531.9%   
Interest Rs m3,630189 1,923.6%   
Profit before tax Rs m16,3555,465 299.3%   
Minority Interest Rs m40-   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m-7,5210-   
Tax Rs m11,5711,042 1,110.0%   
Profit after tax Rs m-2,6944,422 -60.9%  
Gross profit margin %16.218.3 88.4%  
Effective tax rate %70.819.1 370.9%   
Net profit margin %-1.811.7 -15.0%  
BALANCE SHEET DATA
Current assets Rs m154,13223,778 648.2%   
Current liabilities Rs m92,25210,975 840.6%   
Net working cap to sales %40.233.9 118.6%  
Current ratio x1.72.2 77.1%  
Inventory Days Days82104 79.1%  
Debtors Days Days12966 196.1%  
Net fixed assets Rs m89,08220,368 437.4%   
Share capital Rs m906253 358.5%   
"Free" reserves Rs m124,46130,971 401.9%   
Net worth Rs m125,36731,224 401.5%   
Long term debt Rs m17,9331,409 1,273.2%   
Total assets Rs m249,83945,507 549.0%  
Interest coverage x5.530.0 18.4%   
Debt to equity ratio x0.10 317.1%  
Sales to assets ratio x0.60.8 74.2%   
Return on assets %0.410.1 3.7%  
Return on equity %-2.114.2 -15.2%  
Return on capital %8.717.3 50.4%  
Exports to sales %045.9 0.0%   
Imports to sales %016.6 0.0%   
Exports (fob) Rs mNA17,308 0.0%   
Imports (cif) Rs mNA6,266 0.0%   
Fx inflow Rs m51,45017,308 297.3%   
Fx outflow Rs m19,4706,266 310.7%   
Net fx Rs m31,98011,042 289.6%   
CASH FLOW
From Operations Rs m14,6884,923 298.4%  
From Investments Rs m11,070-1,563 -708.2%  
From Financial Activity Rs m-8,906-1,832 486.1%  
Net Cashflow Rs m16,8531,528 1,103.1%  

Share Holding

Indian Promoters % 46.6 45.9 101.5%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 11.4 99.1%  
FIIs % 31.9 25.3 126.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.4 58.0%  
Shareholders   98,259 36,892 266.3%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DR. DATSONS LABS  DISHMAN PHARMA  TTK HEALTHCARE  JUBILANT PHARMOVA   DIVIS LABORATORIES  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


May 7, 2021 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS